GO:0042219 modified amino acid catabolic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042219 (modified amino acid catabolic process) describes the biological process by which cells break down amino acids that carry post-translational or chemical modifications, rather than the 20 standard proteogenic amino acids.
• The process is essential for recycling methylated, glycosylated, phosphorylated and otherwise derivatized amino acids, and for preventing the accumulation of toxic modified intermediates.
• Key enzyme families include methyltransferases and demethylases, calpain proteases, amino acid exchangers such as SLC7A/SLC3A2, and amino acid sensing regulators.
• Dysregulation of modified amino acid catabolism is linked to cardiometabolic disease, cancer metabolism, neurodegeneration and stress responses.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the primary tools for dissecting causal roles of genes in this process.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study modified amino acid catabolic process genes at scale.
Description
GO:0042219, modified amino acid catabolic process, is a Gene Ontology biological process term that covers the breakdown of amino acids bearing covalent modifications such as methylation, glycosylation, phosphorylation or other derivatizations. Unlike the catabolism of standard proteogenic amino acids, this process handles substrates that have been chemically altered after synthesis or during protein turnover, and it is therefore tightly coupled to post-translational modification (PTM) biology and protein quality control. Researchers study this term because modified amino acids are not merely waste products; they are signaling molecules, metabolic intermediates and biomarkers whose catabolic fate influences cell stress responses, redox balance and disease progression. The QuickGO record for GO:0042219 does not currently provide a formal definition, so this article builds its description from the authoritative ontology placement and from peer-reviewed literature on modified amino acid metabolism. Understanding this process is critical for cancer metabolism, cardiometabolic research, neurobiology and synthetic biology, where engineered genetic codes and biocatalytic amino acid functionalisation are increasingly used.
modified amino acid catabolic process At A Glance
| GO ID | GO:0042219 |
|---|---|
| GO term | modified amino acid catabolic process |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Major function | Catabolism of amino acids carrying post-translational or chemical modifications |
| Related modifications | Methylation, glycosylation, phosphorylation, oxidation and other PTMs |
| Key enzyme classes | Methyltransferases/demethylases, calpains, amino acid exchangers, amino acid sensing regulators |
| Disease relevance | Cardiometabolic disease, cancer metabolism, neurodegeneration, stress mitigation |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, proteomics, metabolomics, library screening |
What Is GO:0042219?
In our own words, GO:0042219 (modified amino acid catabolic process) is the set of biochemical reactions and regulatory steps through which a cell degrades amino acids that carry post-translational or chemical modifications. It encompasses the enzymatic removal, conversion or detoxification of modified amino acid species generated by methylation, glycosylation, phosphorylation, oxidation and related modifications, and it feeds the resulting carbon and nitrogen skeletons into central metabolism. The term is a biological process, meaning it describes a programmed series of molecular events rather than a single molecular function or cellular component.
Why Is modified amino acid catabolic process Important in Cell Biology?
Modified amino acid catabolic process matters because it sits at the intersection of protein turnover, post-translational modification biology and cellular stress management. When this process is impaired, modified amino acids and their derivatives can accumulate, altering redox homeostasis, lipid metabolism and signaling pathways that drive cardiometabolic disease and cancer. Conversely, understanding the catabolic routes of modified amino acids enables rational design of biocatalysts and synthetic genetic codes for industrial and therapeutic applications.
• Maintains cellular homeostasis by clearing modified amino acids produced during protein turnover and PTM cycles.
• Prevents toxicity from accumulated methylated, glycosylated or oxidized amino acid intermediates.
• Links amino acid sensing to lipid peroxidation and lipid droplet-dependent antioxidant responses.
• Supports stress mitigation through SLC3A2 N-glycosylation and Golgi remodeling of SLC7A amino acid exchangers.
• Contributes to cardiometabolic disease mechanisms via calpain-mediated proteolysis.
• Influences protein digestion and absorption outcomes in nutrition and food processing research.
• Provides a basis for biocatalytic amino acid functionalisation in drug discovery.
• Enables engineering of amino acid-swapped genetic codes for synthetic biology.
• Serves as a source of biomarkers and drug targets in cancer and metabolic disorders.
• Requires precise CRISPR models to distinguish causal genes from correlative changes.
What Happens During modified amino acid catabolic process?
Recognition and modification of amino acid substrates
In simple terms: First, the cell tags or recognizes amino acids that have been chemically modified.
The process begins when amino acids carrying post-translational modifications such as methylation, glycosylation or phosphorylation are recognized as catabolic substrates. Protein methylation is a major source of modified amino acids, and the enzymes that add or remove methyl groups set the stage for subsequent catabolism. Post-translational modification-associated protein-protein interactions further determine which modified amino acids are channeled into degradation pathways.
Enzymatic cleavage and de-modification
In simple terms: Enzymes then cut off or remove the chemical tags so the amino acid can be broken down.
Calpain proteases and related enzymes cleave modified proteins and peptides, releasing modified amino acids for further processing. Demethylases and other de-modifying enzymes remove covalent marks, converting modified amino acids into catabolizable intermediates. Biocatalytic amino acid functionalisation studies show that these enzymatic steps can be harnessed or redirected for synthetic purposes.
Transport and exchange across membranes
In simple terms: Special transporter proteins move the modified amino acids into the compartments where they are broken down.
SLC7A amino acid exchangers, regulated by SLC3A2 N-glycosylation and Golgi remodeling, mediate the transport of amino acids and their modified derivatives across membranes. This transport is essential for stress mitigation and for supplying catabolic enzymes with their substrates. Amino acid sensing regulators coordinate transport with lipid peroxidation and lipid droplet-dependent antioxidant responses.
Entry into central carbon and nitrogen metabolism
In simple terms: The broken-down pieces feed into the cell's main energy and building-block pathways.
Once de-modified, the carbon skeletons of modified amino acids enter central metabolic pathways, while nitrogen is processed through ammonia-handling systems. Protein digestion and absorption studies show that food processing influences how efficiently these amino acids are released and catabolized. The resulting metabolites can modulate redox balance and lipid metabolism.
Regulation by amino acid sensing and stress pathways
In simple terms: The cell monitors amino acid levels and adjusts the breakdown rate accordingly.
Amino acid sensing regulators link the catabolic process to lipid peroxidation and antioxidant responses, ensuring that modified amino acid catabolism is tuned to cellular stress. SLC3A2-dependent Golgi remodeling further adjusts exchanger activity under stress. Calpain activity in cardiometabolic disease illustrates how dysregulated catabolism contributes to pathology.
Key Genes Involved in GO:0042219 modified amino acid catabolic process
The following genes and proteins are experimentally implicated in modified amino acid catabolic process and related pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC3A2 | N-glycosylation-dependent regulation of SLC7A amino acid exchangers | Stress mitigation and Golgi remodeling studies |
| SLC7A family | Amino acid exchange across membranes | Transport of modified amino acids |
| CAPN1 | Calpain protease activity | Cardiometabolic disease mechanisms |
| CAPN2 | Calpain protease activity | Proteolysis of modified proteins |
| PCMT1 | Protein repair methyltransferase | Methylated amino acid catabolism |
| METTL family | Protein methylation | Source of modified amino acids |
| KDM family | Demethylation of modified amino acids | De-modification steps |
| GCN2 | Amino acid sensing kinase | Links sensing to catabolism |
| mTOR | Amino acid sensing and growth control | Regulates catabolic vs anabolic balance |
| SESN2 | Stress response to amino acid imbalance | Antioxidant response |
| ASNS | Asparagine synthesis and amino acid balance | Metabolic stress studies |
| GOT1 | Aspartate aminotransferase | Central carbon metabolism entry |
| GOT2 | Aspartate aminotransferase | Central carbon metabolism entry |
| GLUD1 | Glutamate dehydrogenase | Nitrogen handling |
| SLC1A5 | Glutamine transport | Amino acid exchange |
| SLC7A11 | Cystine/glutamate exchange | Redox and stress response |
| ATF4 | Stress-responsive transcription factor | Regulates catabolic gene expression |
How Is modified amino acid catabolic process Regulated?
Modified amino acid catabolic process is regulated at multiple levels. Amino acid sensing pathways, including GCN2 and mTOR signaling, detect amino acid availability and adjust catabolic flux accordingly. SLC3A2 N-glycosylation and Golgi remodeling control the surface expression and activity of SLC7A exchangers, thereby gating substrate access to catabolic enzymes. Calpain-mediated proteolysis provides a rapid post-translational layer of regulation that is particularly relevant in cardiometabolic disease. Protein methylation and demethylation cycles further tune the pool of modified amino acids available for catabolism.
modified amino acid catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAPN1 | Cardiometabolic disease | Knockout and point-mutation cardiomyocyte models |
| CAPN2 | Cardiometabolic disease | Knockout and overexpression models |
| SLC3A2 | Cancer and stress mitigation | Knock-in glycosylation mutants |
| SLC7A11 | Redox imbalance and cancer | Knockout and overexpression models |
| PCMT1 | Protein repair and neurodegeneration | Knockout and tagged knock-in models |
Cardiometabolic disease
Calpain overactivation and dysregulated modified amino acid catabolism contribute to cardiac and metabolic pathology, making CAPN1 and CAPN2 candidate therapeutic targets. Altered amino acid sensing and lipid peroxidation responses further link this process to cardiometabolic risk.
Cancer metabolism
Tumor cells reprogram amino acid transport and catabolism to sustain growth and manage oxidative stress. SLC7A exchangers and SLC3A2-dependent regulation are frequently altered in cancer, and modified amino acid catabolism supports redox balance and biosynthetic demand.
Neurodegeneration and proteinopathy
Impaired clearance of methylated and oxidized amino acids is implicated in protein aggregation and neuronal stress. Protein methylation and demethylation imbalance can contribute to neurodegeneration through accumulation of modified protein species.
Metabolic stress and antioxidant response
Amino acid sensing regulators link modified amino acid catabolism to lipid droplet-dependent antioxidant responses, and their failure exacerbates oxidative damage in metabolic tissues.
From modified amino acid catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the gene required for modified amino acid catabolism? | CRISPR knockout cell line |
| Does a specific residue control enzyme activity? | Point-mutation knock-in |
| How does a disease variant affect catabolism? | Knock-in of patient variant |
| Where is the protein localized during catabolism? | Tagged knock-in (e.g., GFP/HA) |
| Does overexpression rescue a catabolic defect? | Overexpression cell model |
| Which genes cooperate in the pathway? | CRISPR library screening |
How to Study the modified amino acid catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene requirement for catabolism | Discovery of pathway regulators |
| Proteomics | Modified amino acid and protein abundance | PTM mapping |
| Metabolomics | Catabolic intermediates and end products | Flux and pathway analysis |
| Isotope tracing | Metabolic flux | Quantifying catabolic rates |
| Western blot | Protein expression and cleavage | Calpain activity assays |
| Immunofluorescence | Subcellular localization | Golgi and lipid droplet studies |
| RNA-seq | Transcriptional response | Stress and sensing pathway analysis |
| CRISPR library screening | Fitness and resistance genes | Pathway-wide interrogation |
CRISPR-based genetic screens
Pooled CRISPR knockout and activation screens identify genes required for modified amino acid catabolism and reveal genetic interactions. These screens are particularly useful for discovering unanticipated regulators of amino acid sensing and transport.
Proteomics and PTM profiling
Mass spectrometry-based proteomics maps post-translational modifications on amino acids and proteins, quantifying the modified species that feed into catabolism. PTM-associated protein-protein interaction studies further define the machinery involved.
Metabolomics and flux analysis
Metabolomic profiling measures modified amino acid levels and their catabolic products, while isotope tracing quantifies flux through the pathway. These methods link genotype to metabolic phenotype.
Imaging and subcellular localization
Fluorescence imaging of tagged catabolic enzymes and transporters reveals their subcellular distribution, including Golgi and lipid droplet associations. This is essential for understanding compartmentalized catabolism.
How CRISPR Can Be Used to Study GO:0042219 modified amino acid catabolic process
Knockout
CRISPR knockout cell lines eliminate candidate genes to test whether they are required for modified amino acid catabolism. This approach is widely used for CAPN1, CAPN2, SLC3A2 and SLC7A family genes. Knockout models provide causal evidence that complements correlative metabolomic data.
Point Mutation
Point-mutation knock-in models introduce specific amino acid substitutions to dissect catalytic residues, glycosylation sites or regulatory phosphorylation sites. These models are essential for separating enzymatic activity from scaffolding functions.
Knock-in
Knock-in of tagged or disease-associated alleles enables tracking of catabolic enzymes in live cells and tissues. Tagged knock-in models are particularly valuable for imaging subcellular localization during stress.
Overexpression
Overexpression models test whether increased levels of a catabolic enzyme or transporter are sufficient to alter pathway flux or rescue a defect. They are commonly used for SLC7A exchangers and amino acid sensing regulators.
How EDITGENE Supports modified amino acid catabolic process Research
Researchers studying modified amino acid catabolic process-related genes often need to determine whether a candidate gene is causally involved in substrate handling, transport or stress response, rather than merely correlating with pathway activity. Rigorous causal testing requires precisely engineered cell models that control gene dosage, catalytic activity and localization.
Contact EDITGENE today to design your custom CRISPR model for modified amino acid catabolic process research.
Frequently Asked Questions About modified amino acid catabolic process
What is GO:0042219 modified amino acid catabolic process?
GO:0042219 is a Gene Ontology biological process term describing the breakdown of amino acids that carry post-translational or chemical modifications, such as methylation or glycosylation.
What genes are involved in modified amino acid catabolic process?
Genes include SLC3A2, SLC7A family exchangers, CAPN1, CAPN2, PCMT1, METTL family methyltransferases, KDM demethylases and amino acid sensing regulators such as GCN2 and mTOR.
Why is modified amino acid catabolism important?
It clears modified amino acids, prevents toxic accumulation, supports redox balance and links amino acid sensing to antioxidant and stress responses.
How is modified amino acid catabolic process regulated?
It is regulated by amino acid sensing pathways, SLC3A2-dependent Golgi remodeling, calpain proteolysis and methylation/demethylation cycles.
What diseases are linked to modified amino acid catabolism?
Cardiometabolic disease, cancer metabolism, neurodegeneration and metabolic stress disorders have been linked to dysregulation of this process.
How do you study modified amino acid catabolic process?
Common methods include CRISPR knockout and library screening, proteomics, metabolomics, isotope tracing, imaging and RNA-seq.
What CRISPR models are used for modified amino acid catabolism research?
Knockout, point-mutation, knock-in, tagged knock-in and overexpression cell models are used to test causality and mechanism.
Can EDITGENE help with modified amino acid catabolic process research?
Yes, EDITGENE provides knockout, point-mutation, knock-in, overexpression, library screening and bioinformatics services for these genes.
What is the role of SLC3A2 in modified amino acid catabolism?
SLC3A2 N-glycosylation and Golgi remodeling regulate SLC7A amino acid exchangers and stress mitigation, controlling substrate access to catabolic pathways.
How does calpain relate to modified amino acid catabolic process?
Calpain proteases cleave modified proteins and peptides, releasing modified amino acids for catabolism, and their dysregulation is linked to cardiometabolic disease.
Conclusion
GO:0042219 modified amino acid catabolic process is a biologically and clinically significant ontology term that connects post-translational modification biology, amino acid transport, stress sensing and metabolic disease. Its study requires precise genetic models and multi-omics approaches to move from correlation to causation. EDITGENE's CRISPR cell model and screening services provide the experimental infrastructure needed to interrogate this pathway in health and disease.
References
- 1. Wang S et al.. 2022. Uncovering post-translational modification-associated protein-protein interactions.. Curr Opin Struct Biol 74:102352 PMID: 35334254
- 2. Li J et al.. 2025. A regulator of amino acid sensing links lipid peroxidation and lipid droplet-dependent antioxidant response.. Mol Cell 85(17):3225-3240.e10 PMID: 40865521
- 3. Loveday SM. 2023. Protein digestion and absorption: the influence of food processing.. Nutr Res Rev 36(2):544-559 PMID: 36522674
- 4. Petchey MR et al.. 2025. Biocatalytic Amino Acid Functionalisation.. ChemMedChem 20(5):e202400628 PMID: 39540701
- 5. Miyazaki T. 2023. Calpain and Cardiometabolic Diseases.. Int J Mol Sci 24(23) PMID: 38069105
- 6. Zhang C et al.. 2023. SLC3A2 N-glycosylation and Golgi remodeling regulate SLC7A amino acid exchangers and stress mitigation.. J Biol Chem 299(12):105416 PMID: 37918808
- 7. Fujino T et al.. 2020. An Amino Acid-Swapped Genetic Code.. ACS Synth Biol 9(10):2703-2713 PMID: 32882137
- 8. Clarke S. 1993. Protein methylation.. Curr Opin Cell Biol 5(6):977-83 PMID: 8129951
